Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	21829-25-4
Formula :	C₁₇H₁₈N₂O₆
M.W :	346.33
SMILES Code :	O=C(C1=C(C)NC(C)=C(C(OC)=O)C1C2=CC=CC=C2[N+]([O-])=O)OC
Synonyms :	BAY-a-1040; BAY 1040
MDL No. :	MFCD00057326
InChI Key :	HYIMSNHJOBLJNT-UHFFFAOYSA-N
Pubchem ID :	4485

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H351-H361
Precautionary Statements:	P280-P305+P351+P338

Gastric fundus smooth muscle cells	10 µM		Nifedipine was used to block L-type calcium currents to study the electrophysiological properties of gastric fundus smooth muscle cells	Int J Mol Sci. 2023 Jan 5;24(2):1082.
HVC X neurons	10 μM		Used to block L-type calcium channels to study their effect on neuronal activity.	Nat Commun. 2020 Feb 19;11(1):952.
Rat aortic smooth muscle cells	25 nM and 100 nM	30 min	To investigate the effect of Nifedipine on Ang II-induced NADPH oxidase activity, results showed that Nifedipine significantly attenuated Ang II-induced NADPH oxidase activity.	J Mol Cell Cardiol. 2015 Oct;87:152-9.
Human myometrial smooth muscle cells (PHM1-41)	10 µM	48 h	To assess the effect of nifedipine on the contractility of myometrial smooth muscle cells. Results showed that nifedipine inhibited TNF/LPS-induced contraction, maintaining a level of contraction similar to the basal vehicle control conditions at 48 h.	Sci Rep. 2023 Apr 6;13(1):5646.
Human myometrial smooth muscle cells (PHM1-41)	10 µM	24 h	To assess the effect of nifedipine on the inflammatory response of myometrial smooth muscle cells. Results showed that nifedipine did not reduce TNF or LPS-induced pro-inflammatory cytokine gene expression.	Sci Rep. 2023 Apr 6;13(1):5646.
CAFs	2.5 μM	24 h	To evaluate the effect of Nifedipine on CAF activated phenotype, results showed that Nifedipine reduced CAF motility and ECM remodeling ability	J Exp Clin Cancer Res. 2024 Jun 11;43(1):161.
WPMY-1	2.5 μM		To evaluate the effect of Nifedipine on inward current in WPMY-1 cells, results showed that Nifedipine significantly reduced the inward current	J Exp Clin Cancer Res. 2024 Jun 11;43(1):161.
Gastric smooth muscle cells	10 μM	1-2 min	Nifedipine was used to block L-type Ca2+ channels to study the effect of ADPN on Ca2+ currents in gastric smooth muscle cells. The results showed that ADPN reduced the amplitude of Ca2+ currents.	Int J Mol Sci. 2020 Dec 17;21(24):9617.
LNCaP	70 μM	24 h	To study the effects of Nifedipine on prostate cancer cells, the results showed that 635 proteins (12.61%) showed significant differences between the treatment and control groups, including 89 upregulated proteins and 147 downregulated proteins.	Cancer Biol Med. 2021 Apr 24;19(1):74–89.
DU145	26.66 ± 19.26 μM	72 h	To study the effects of Nifedipine on prostate cancer cells, the results showed that Nifedipine produced dose-dependent antiproliferative effects in DU145 cells.	Cancer Biol Med. 2021 Apr 24;19(1):74–89.
MGC-803	20.73 ± 10.10 μM	72 h	To study the effects of Nifedipine on gastric cancer cells, the results showed that Nifedipine showed toxicity in the MGC-803 cell line.	Cancer Biol Med. 2021 Apr 24;19(1):74–89.

C57BL/6 mice	SFTSV infection model	Intragastric administration	100 mg/kg	Twice a day for 7 days	Benidipine hydrochloride and nifedipine significantly reduced viral loads in spleen and serum, and alleviated SFTSV-induced pathogenesis.	Cell Res. 2019 Sep;29(9):739-753.
Mice	FVB/N mice	Apical administration	10 µmol/L	Single dose	To evaluate the effect of nifedipine on Ca2+ absorption in the ileum of P14 mice, results showed that nifedipine significantly inhibited Ca2+ absorption.	Cell Mol Gastroenterol Hepatol. 2019;8(4):625-642
Mice	Awake and freely moving CD-1 male mice	Intraperitoneal injection	1 mg/kg	Single administration, observed for 5 hours	Nifedipine (1 mg/kg) did not significantly alter the basal HR in vehicle-treated mice, and it did not modify the effect provoked by JWH-018 injection. The JWH-018-induced tachyarrhythmias were slightly reduced after nifedipine injection in the last two hours of experiment. Nifedipine slightly reduced basal BR one hour following the treatment, and in JWH-018-pretreated mice, it abolished the reduction of breath rate during the first hour of the experiment. The effect on oxygen saturation subsequent to nifedipine administration did not reveal a difference from the vehicle. However, nifedipine was able to slightly increase oxygen saturation immediately after injection when it was administered after JWH-018.	Int J Mol Sci. 2023 Apr 19;24(8):7515
Hph-1 mice	Ang II-induced abdominal aortic aneurysm model	Oral	5 mg/kg and 20 mg/kg	Once daily for 14 days	To investigate the effect of Nifedipine on the formation of abdominal aortic aneurysm, results showed that Nifedipine significantly reduced the incidence of AAA and improved eNOS coupling state and NO bioavailability.	J Mol Cell Cardiol. 2015 Oct;87:152-9.
Mice	LPS-induced preterm birth model	Intraperitoneal injection	1 mg/kg or 10 mg/kg	Every 24 hours until birth	To assess the effect of nifedipine on preventing LPS-induced preterm birth. Results showed that nifedipine was unable to consistently delay preterm birth, although it prolonged pregnancy in some mice.	Sci Rep. 2023 Apr 6;13(1):5646.
SCID mice	Prostate cancer xenograft model	Intratumoral injection	250 μl	5 consecutive days for 2 weeks	To evaluate the effect of Nifedipine-treated CAF conditioned medium on prostate cancer xenograft growth, results showed that Nifedipine significantly attenuated tumor growth	J Exp Clin Cancer Res. 2024 Jun 11;43(1):161.
Male nude mice	Prostate cancer xenograft model	Intraperitoneal injection	50 mg/kg	Daily for 15 days	To study the effects of Nifedipine on prostate tumor growth, the results showed that Nifedipine significantly inhibited the growth and proliferation of tumors.	Cancer Biol Med. 2021 Apr 24;19(1):74–89.

{[proInfo.proName]}

CAS No.: 21829-25-4

{[proInfo.proName]}

CAS No.: 21829-25-4

Product Citations

Alternative Products

Product Details of Nifedipine

Safety of Nifedipine

Related Pathways of Nifedipine

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT00137501	Labor, Premature	PHASE3	TERMINATED	2025-06-09	American University of Beirut ... More >>Medical Center, Beirut, Lebanon Less <<
NCT00185952	Obstetric Labor, Premature\|Ven... More >>ous Thrombosis Less <<		COMPLETED	2025-08-08	Stanford University School of ... More >>Medicine, Stanford, California, 94305, United States Less <<
NCT02072291	Embryo Implantation	PHASE2	UNKNOWN	2025-06-18	Hadassah Medical Organization,... More >> Jerusalem, Israel Less <<
NCT01351428	Pre-Eclampsia\|Pregnancy\|Hypert... More >>ension Less <<		COMPLETED	2025-11-12	Mount Sinai Hospital, Toronto,... More >> Ontario, M5G1X5, Canada Less <<
NCT00000102	Congenital Adrenal Hyperplasia	PHASE1\|PHASE2	COMPLETED	-	Medical University of South Ca... More >>rolina, Charleston, South Carolina, United States Less <<
NCT02527109	Chronic Anal Fissure	PHASE2\|PHASE3	COMPLETED	2018-08-22	UMHAT "Sveti Georgi", Internal... More >> Consulting Department, Plovdiv, Bulgaria\|"Multiprofile Hospital for Active Treatment - Doverie" AD, Clinic of Gastroenterology, Sofia, 1632, Bulgaria\|II MHAT, Internal Clinic, Department of Gastroenterology, Sofia, Bulgaria\|MC Health BG EOOD, Sofia, Bulgaria\|Multiprofile Hospital for Active Treatment Lulin, Sofia, Bulgaria\|MC "New rehabilitation centre'' EOOD, Stara Zagora, Bulgaria\|"Multiprofile Regional Hospital for Active Treatment - Dr. St. Cherkezov" AD Department of Gastroenterology, Veliko Tarnovo, 5002, Bulgaria\|IMSP Spitalul Clinic Municipal Nr 1, Chisinau, Moldova, Republic of\|IMSP Spitalul Clinic Municipal Nr 3 "Sfanta Treime", Chisinau, Moldova, Republic of\|IMSP Spitalul Clinic Republican, Chisinau, Moldova, Republic of\|Med-Gastr Centrum Medyczne, Lodz, 91-034, Poland\|Ambulatorium Medyczne Medical Hair & Esthetic, Lublin, 20-844, Poland\|Centrum Innowacyjnych Terapii Sp. z o.o. Oddzia? w Piasecznie, Piaseczno, 05-500, Poland\|NZOZ Specjalistyczne Centrum Medyczne Flebo, Wolomin, 05-200, Poland\|Pelican Impex SRL, Oradea, Jud. Bihor, 410469, Romania\|IRGH, Cluj Napoca, Jud. Cluj, 400162, Romania\|Tvm Med Serv Srl, Cluj Napoca, Jud. Cluj, Romania\|Institutul Regional de Gastroenterologie si Hepatologie "Prof. Dr. Octavian Fodor", Cluj-Napoca, Jud. Cluj, 400162, Romania\|SC Schnelbach Medical Care SRL, Ploiesti, Jud. Prahova, Romania\|Spit. Clinic Judetean de Urgenta "Sf. Apostol Andrei" Constanta, Constanta, Judet Constanta, Romania\|Dacmed SRL, Ploiesti, Judetul Prahova, Romania\|Centrul Medical de Diagnostic si Tratament Ambulator Neomed SRL, Brasov, 500283, Romania\|Institutul Clinic Fundeni, Bucharest, 022328, Romania\|Centrul Medical Sfanta Vineri SRL, Bucharest, Romania Less <<
NCT02090920	Preterm Labor		COMPLETED	2025-04-19	Eskenazi Health, Indianapolis,... More >> Indiana, 46202, United States\|IU Health Methodist, Indianapolis, Indiana, 46202, United States Less <<
NCT00244530	Kidney Failure, Chronic\|Corona... More >>ry Artery Disease Less <<	PHASE4	COMPLETED	2025-10-05	Rikshospitalet University Hosp... More >>ital, Oslo, 0027, Norway Less <<
NCT02068404	Preterm Labor	PHASE4	UNKNOWN	2025-01-16	Centre Hospitalier Universitai... More >>re Vaudois, Lausanne, Vaud, 1011, Switzerland Less <<

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	2.89mL 0.58mL 0.29mL	14.44mL 2.89mL 1.44mL	28.87mL 5.77mL 2.89mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed